Cardinal Plans Generic Cardiolite, Other Moves To Expand Generic Presence

Cardinal Health expects to market its own generic version of Bristol-Myers Squibb's cardiac imaging agent Cardiolite (technetium Tc99m sestamibi) as part of a plan to expand its role in the generic sector

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet